Abstract
Sickle cell disease (SCD) is associated with increased levels of hospitalization, morbidity, and mortality.1 Managed care is a strategy intended to reduce healthcare costs2 but no research exists on the effects of managed care on SCD patients. In this study, we examine the impact of managed care and hospital characteristics on utilization of inpatient care for SCD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
